DANA MASON: Open Payments
NPI 1801195862 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 58 payments from 16 companies in 2025. Trend: 2023 $960 · 2024 $1,355 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $478 |
| AstraZeneca Pharmaceuticals LP | 4 | $342 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Lilly USA, LLC | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| PFIZER INC. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: Wegovy, AIRSUPRA, Ozempic, REXULTI, BREZTRI, TRELEGY ELLIPTA, Rybelsus, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
